FAST NEWS: Luye Pharma’s Schizophrenia Drug Wins FDA Approval
The latest: Drug maker Luye Pharma Group Ltd. announced Sunday that its drug Rykindo has been approved by the U.S. Food and Drug Administration (FDA) as a treatment for schizophrenia…
Recent Articles
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK -
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
